Stonepine Capital Management, LLC Quant / Systematic

Name: Stonepine Capital Management, LLC Q4 2018 13F Filing | 13F Explorer
Creator: Stonepine Capital Management, LLC
Published: 2019-02-13

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q4 2018 (← Previous) (Next →)

Filing Date: Feb 13, 2019

Total Value: $114M (100.0% shares, 0.0% debt)

Holdings (22)

— AMARIN CORP PLC 13.1%

Value $14.97M Shares 1,100,000 Est. Cost $3.01 Unrealized —

— BIODELIVERY SCIENCES INTL 12.9%

Value $14.73M Shares 3,981,867 Est. Cost $2.54 Unrealized —

— BIOSPECIFICS TECHNOLOGIES 11.6%

Value $13.17M Shares 217,395 Est. Cost $45.13 Unrealized —

CPIX CUMBERLAND PHARMACEUTICALS 7.0%

Value $7.92M Shares 1,313,429 Est. Cost $5.84 Unrealized +2.5%

— APOLLO ENDOSURGERY INC 6.6%

Value $7.54M Shares 2,185,426 Est. Cost $4.75 Unrealized —

— NEOS THERAPEUTICS INC 6.1%

Value $6.947M Shares 4,210,153 Est. Cost $1.82 Unrealized —

— HTG MOLECULAR DIAGNOSTICS 6.0%

Value $6.797M Shares 2,675,889 Est. Cost $2.68 Unrealized —

VNDA VANDA PHARMACEUTICALS INC 5.1%

Value $5.771M Shares 220,848 Est. Cost $14.90 Unrealized +57.8%

— OPIANT PHARMACEUTICALS INC 4.5%

Value $5.173M Shares 357,960 Est. Cost $16.22 Unrealized —

— OPHTHOTECH CORP 4.3%

Value $4.887M Shares 4,072,301 Est. Cost $2.69 Unrealized —

— ALIMERA SCIENCES INC 4.1%

Value $4.702M Shares 6,547,774 Est. Cost $1.18 Unrealized —

— FOAMIX PHARMACEUTICALS LTD 4.1%

Value $4.643M Shares 1,293,177 Est. Cost $4.50 Unrealized —

— CTI BIOPHARMA CORP 3.7%

Value $4.201M Shares 5,726,579 Est. Cost $3.06 Unrealized —

— VIVEVE MEDICAL INC 3.2%

Value $3.589M Shares 3,418,402 Est. Cost $6.92 Unrealized —

— OXFORD IMMUNOTEC GLOBAL PLC 2.5%

Value $2.841M Shares 222,321 Est. Cost $16.23 Unrealized —

— AFFIMED NV 2.0%

Value $2.221M Shares 714,079 Est. Cost $3.11 Unrealized —

— CORREVIO PHARMA CORP 0.9%

Value $1.056M Shares 424,101 Est. Cost $3.78 Unrealized —

— CHEMBIO DIAGNOSTICS INC 0.7%

Value $832K Shares 147,011 Est. Cost $5.66 Unrealized —

ATEC ALPHATEC HOLDINGS INC 0.7%

Value $775K Shares 338,278 Est. Cost $3.55 Unrealized -20.6%

— MOLECULAR TEMPLATES INC 0.4%

Value $463K Shares 114,710 Est. Cost $5.39 Unrealized —

— NOVELION THERAPEUTICS INC 0.4%

Value $447K Shares 531,662 Est. Cost $8.14 Unrealized —

— CATABASIS PHARMACEUTICALS IN 0.2%

Value $182K Shares 41,688 Est. Cost $4.37 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	AMARIN CORP PLC	1,100,000	$14.97M	13.1%	$3.01	—	SPONS ADR NEW	023111206
—	BIODELIVERY SCIENCES INTL	3,981,867	$14.73M	12.9%	$2.54	—	COM	09060J106
—	BIOSPECIFICS TECHNOLOGIES	217,395	$13.17M	11.6%	$45.13	—	COM	090931106
CPIX	CUMBERLAND PHARMACEUTICALS	1,313,429	$7.92M	7.0%	$5.84	+2.5%	COM	230770109
—	APOLLO ENDOSURGERY INC	2,185,426	$7.54M	6.6%	$4.75	—	COM	03767D108
—	NEOS THERAPEUTICS INC	4,210,153	$6.947M	6.1%	$1.82	—	COM	64052L106
—	HTG MOLECULAR DIAGNOSTICS	2,675,889	$6.797M	6.0%	$2.68	—	COM	40434H104
VNDA	VANDA PHARMACEUTICALS INC	220,848	$5.771M	5.1%	$14.90	+57.8%	COM	921659108
—	OPIANT PHARMACEUTICALS INC	357,960	$5.173M	4.5%	$16.22	—	COM	683750103
—	OPHTHOTECH CORP	4,072,301	$4.887M	4.3%	$2.69	—	COM	683745103
—	ALIMERA SCIENCES INC	6,547,774	$4.702M	4.1%	$1.18	—	COM	016259103
—	FOAMIX PHARMACEUTICALS LTD	1,293,177	$4.643M	4.1%	$4.50	—	SHS	M46135105
—	CTI BIOPHARMA CORP	5,726,579	$4.201M	3.7%	$3.06	—	COM NEW	12648L601
—	VIVEVE MEDICAL INC	3,418,402	$3.589M	3.2%	$6.92	—	COM NEW	92852W204
—	OXFORD IMMUNOTEC GLOBAL PLC	222,321	$2.841M	2.5%	$16.23	—	ORD SHS	G6855A103
—	AFFIMED NV	714,079	$2.221M	2.0%	$3.11	—	COM	N01045108
—	CORREVIO PHARMA CORP	424,101	$1.056M	0.9%	$3.78	—	COM	22026V105
—	CHEMBIO DIAGNOSTICS INC	147,011	$832K	0.7%	$5.66	—	COM NEW	163572209
ATEC	ALPHATEC HOLDINGS INC	338,278	$775K	0.7%	$3.55	-20.6%	COM NEW	02081G201
—	MOLECULAR TEMPLATES INC	114,710	$463K	0.4%	$5.39	—	COM	608550109
—	NOVELION THERAPEUTICS INC	531,662	$447K	0.4%	$8.14	—	COM NEW	67001K202
—	CATABASIS PHARMACEUTICALS IN	41,688	$182K	0.2%	$4.37	—	COM NEW	14875P206